Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MLIP antisense RNA 1 (MLIP-AS1)
- Target
- MLIP-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
MLIP antisense RNA 1 (MLIP-AS1) is a long non-coding RNA gene located antisense to the MLIP gene on chromosome 6. lncRNAs such as MLIP-AS1 are implicated in transcriptional and post-transcriptional regulation, potentially modulating chromatin state or RNA processing. The MLIP-AS1 region has been implicated in influencing patient response to glaucoma treatments, suggesting that copy number variation in this lncRNA may modulate MLIP expression, impacting pharmacological outcomes. There is, however, no evidence that MLIP-AS1 functions as a canonical druggable target such as a receptor or enzyme. Further research is needed to define its precise molecular mechanism and its disease associations[1][2].
- Other names
- MLIP-AS1
02
Mechanism of action
Not applicable; it is not the direct target of any known drugs.
03
Biological functions
Transcriptional regulationPost-transcriptional regulationChromatin modification (putative, based on typical lncRNA functions)
04
Disease associations
Potential biomarker role in pharmacogenomics of glaucoma (primary open-angle glaucoma, ocular hypertension, by influencing response to beta-blockers and prostaglandins via MLIP regulation)Other (no direct evidence for established disease roles yet)
05
Biomarkers
MLIP-AS1/MLIP locus copy number as a potential predictive biomarker for response to timolol maleate and latanoprost in primary open-angle glaucoma and ocular hypertension
Beyond the preview
Go deeper on MLIP antisense RNA 1 (MLIP-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MLIP antisense RNA 1 (MLIP-AS1).